[go: up one dir, main page]

GB0323793D0 - Methods - Google Patents

Methods

Info

Publication number
GB0323793D0
GB0323793D0 GBGB0323793.0A GB0323793A GB0323793D0 GB 0323793 D0 GB0323793 D0 GB 0323793D0 GB 0323793 A GB0323793 A GB 0323793A GB 0323793 D0 GB0323793 D0 GB 0323793D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0323793.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0323793.0A priority Critical patent/GB0323793D0/en
Publication of GB0323793D0 publication Critical patent/GB0323793D0/en
Priority to PCT/GB2004/004210 priority patent/WO2005035786A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0323793.0A 2003-10-10 2003-10-10 Methods Ceased GB0323793D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0323793.0A GB0323793D0 (en) 2003-10-10 2003-10-10 Methods
PCT/GB2004/004210 WO2005035786A2 (en) 2003-10-10 2004-10-06 Methods for the risk estimation of bronchiectasis using ifngamma and cxcr1 gene polymorphisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0323793.0A GB0323793D0 (en) 2003-10-10 2003-10-10 Methods

Publications (1)

Publication Number Publication Date
GB0323793D0 true GB0323793D0 (en) 2003-11-12

Family

ID=29433695

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0323793.0A Ceased GB0323793D0 (en) 2003-10-10 2003-10-10 Methods

Country Status (2)

Country Link
GB (1) GB0323793D0 (en)
WO (1) WO2005035786A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006051886A1 (en) * 2004-11-12 2008-05-29 国立大学法人大阪大学 A method for predicting the possibility of increasing severity of autoimmune diseases that cause functional impairment due to tissue destruction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558661B1 (en) * 1992-12-29 2003-05-06 Genentech, Inc. Treatment of inflammatory bowel disease with IFN-γ inhibitors
DE60230722D1 (en) * 2001-01-16 2009-02-26 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
WO2005035786A2 (en) 2005-04-21
WO2005035786A3 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
EP1615948A4 (en) Immuno-amplification
EP1635758A4 (en) Orthodynamic rehabilitator
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE602004030538D1 (en) Präzisionssubstratlagerbehälter
EP1629178A4 (en) Rockbolt
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
GB0326439D0 (en) Methods
DE502004003476D1 (en) Standfuss
DE602004027010D1 (en) Thermotherapiehülle
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DE60333037D1 (en) Laser-radar
DK1665437T3 (en) Reformeringsmodul
DE602004012262D1 (en) Benzimidazolonverbindung
DE602004020525D1 (en) Imidazolderivate
DE502004012153D1 (en) Rotorspinnmaschine
GB0328243D0 (en) Methods
DE10394343D2 (en) Berührungslose biometrische erkennung
GB0327909D0 (en) Methods
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
GB0320627D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)